» Articles » PMID: 18164911

Metabolic Alterations in Medication-free Patients with Bipolar Disorder: a 3T CSF-corrected Magnetic Resonance Spectroscopic Imaging Study

Overview
Journal Psychiatry Res
Specialty Psychiatry
Date 2008 Jan 1
PMID 18164911
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study was to determine whether cerebrospinal fluid(CSF)-corrected concentrations of N-acetylaspartate are lower in several brain regions of drug- and medication-free subjects with bipolar disorder as compared with matched healthy controls. Bipolar subjects (n=21) and age- and sex-matched healthy control (n=21) were studied using proton magnetic resonance spectroscopic imaging on a 3T magnetic resonance (MR) scanner. Spectra were quantified using the LCModel, and metabolite values were CSF-corrected to yield metabolite concentrations. Fourteen regions of interest and five metabolite concentrations in each subject were selected for statistical analysis. We found that bipolar subjects had significantly decreased N-acetylaspartate concentrations in both caudate heads and the left lentiform nucleus. Choline and creatine in the head of the right caudate were also significantly decreased in bipolar subjects. Significantly increased myo-inositol was found in the left caudate head in bipolar subjects. Bipolar subjects showed significantly decreased glutamate/glutamine concentrations in the frontal white matter bilaterally and in the right lentiform nucleus. No differences were found for other metabolites examined. These preliminary findings suggest decreased neuronal density or viability in the basal ganglia and neurometabolic abnormalities in the frontal lobes of subjects with bipolar disorder.

Citing Articles

Microbiota-gut-brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities.

Ortega M, Alvarez-Mon M, Garcia-Montero C, Fraile-Martinez O, Monserrat J, Martinez-Rozas L Mol Psychiatry. 2023; 28(7):2645-2673.

PMID: 36707651 PMC: 10615769. DOI: 10.1038/s41380-023-01964-w.


Glutamatergic and N-Acetylaspartate Metabolites in Bipolar Disorder: A Systematic Review and Meta-Analysis of Proton Magnetic Resonance Spectroscopy Studies.

Chabert J, Allauze E, Pereira B, Chassain C, De Chazeron I, Rotge J Int J Mol Sci. 2022; 23(16).

PMID: 36012234 PMC: 9409038. DOI: 10.3390/ijms23168974.


A pilot spectroscopy study of adversity in adolescents.

Sonmez A, Lewis C, Port J, Athreya A, Choi D, Zaccariello M Biomark Neuropsychiatry. 2022; 5.

PMID: 35783196 PMC: 9248870. DOI: 10.1016/j.bionps.2021.100043.


Magnetic Resonance Spectroscopy and Bipolar Disorder: How Feasible Is This Pairing?.

Sosa-Moscoso B, Ullauri C, Chiriboga J, Silva P, Haro F, Leon-Rojas J Cureus. 2022; 14(3):e23690.

PMID: 35505758 PMC: 9056012. DOI: 10.7759/cureus.23690.


Glutamatergic Correlates of Bipolar Symptoms in Adolescents.

Sonmez A, Lewis C, Port J, Cabello-Arreola A, Blacker C, Seewoo B J Child Adolesc Psychopharmacol. 2020; 30(10):599-605.

PMID: 33179961 PMC: 7757593. DOI: 10.1089/cap.2020.0082.